Literature DB >> 7692983

Development of interstitial pneumonitis during treatment with granulocyte colony-stimulating factor.

M Katoh, K Shikoshi, M Takada, M Umeda, T Tsukahara, S Kitagawa, T Shirai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7692983     DOI： 10.1007/bf01695869

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  6 in total

1.  Neutrophil-induced injury of rat pulmonary alveolar epithelial cells.

Authors:  R H Simon; P D DeHart; R F Todd
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

2.  Prevention of pulmonary injury in isolated perfused rat lungs by activated human neutrophils preincubated with anti-Mo1 monoclonal antibody.

Authors:  G Ismail; M L Morganroth; R F Todd; L A Boxer
Journal:  Blood       Date:  1987-04       Impact factor: 22.113

3.  In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma.

Authors:  A Ohsaka; S Kitagawa; S Sakamoto; Y Miura; N Takanashi; F Takaku; M Saito
Journal:  Blood       Date:  1989-12       Impact factor: 22.113

4.  Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence.

Authors:  A Yuo; S Kitagawa; A Ohsaka; M Ohta; K Miyazono; T Okabe; A Urabe; M Saito; F Takaku
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

5.  Neutrophil kinetics shortly after initial administration of recombinant human granulocyte colony-stimulating factor: neutrophil alkaline phosphatase activity as an endogenous marker.

Authors:  M Katoh; T Shirai; K Shikoshi; M Ishii; M Saito; S Kitagawa
Journal:  Eur J Haematol       Date:  1992-07       Impact factor: 2.997

6.  Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis.

Authors:  P R Craddock; J Fehr; K L Brigham; R S Kronenberg; H S Jacob
Journal:  N Engl J Med       Date:  1977-04-07       Impact factor: 91.245
  6 in total
  5 in total

Review 1.  Clinical toxicity of cytokines used as haemopoietic growth factors.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

Review 2.  Recombinant methionyl granulocyte colony-stimulating factor (filgrastim): a new dimension in immunotherapy.

Authors:  G Schwab; T Hecht
Journal:  Ann Hematol       Date:  1994-07       Impact factor: 3.673

3.  Risks of rhG-CSF treatment in drug-induced agranulocytosis.

Authors:  H Demuynck; P Zachée; G E Verhoef; M Schetz; G Van den Berghe; P Lauwers; M A Boogaerts
Journal:  Ann Hematol       Date:  1995-03       Impact factor: 3.673

4.  Interstitial pneumonia in patients receiving granulocyte colony-stimulating factor during chemotherapy: survey in Japan 1991-96.

Authors:  N Niitsu; S Iki; K Muroi; S Motomura; M Murakami; H Takeyama; A Ohsaka; A Urabe
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Pulmonary toxicity after granulocyte colony-stimulating factor-combined chemotherapy for non-Hodgkin's lymphoma.

Authors:  N Yokose; K Ogata; H Tamura; E An; K Nakamura; K Kamikubo; S Kudoh; K Dan; T Nomura
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.